Cancer patient gets new lease on life through clinical trial
Arizona resident Evelyn Sorensen is in a far different place today than she was six months ago, thanks to a cutting-edge cancer clinical trial being conducted at the Virginia G. Piper Cancer Center at Scottsdale Healthcare in partnership with the Translational Genomics Research Institute (TGen).
When Sorensen was diagnosed with stage two cervical cancer two years ago, she underwent rounds of chemotherapy and radiation. But the cancer eventually spread to her lymph nodes. Doctors told her they were inoperable, and there were no other standard treatment options available to her.
I was out of options, and I wasnt happy to hear that, said Sorensen, a resident of Mesa. Im 47 years old and Im not ready to say goodbye just yet.
Sorensen then learned of the BIND-014 clinical trial being conducted through Virginia G. Piper Cancer Center Clinical Trials, and quickly joined the study in August of 2011. Virginia G. Piper Cancer Center Clinical Trials is a partnership between Scottsdale Healthcare and TGen that treats cancer patients with promising new drugs.
BIND-014, created by BIND Biosciences in Cambridge, Mass., is being studied in patients with advanced or metastatic cancer. It uses microscopic drones to deliver medicine directly to cancer cells, increasing the drugs effectiveness and minimizing side effects. The study is led in Scottsdale by Dr. Daniel Von Hoff, chief scientific officer at Scottsdale Healthcare and physician-in-chief at TGen.
After her first treatment on the study in September 2011, Sorensens tumors began to shrink rapidly. Today, doctors say her cancer has diminished substantially, although she still takes the medication to maintain the results. Sorensen is beyond thrilled with the outcomes.
I didnt even have any of the horrible side effects that are associated with chemotherapy such as weight loss or hair loss, she said. I even joked with Dr. Von Hoff that I thought he was giving me a placebo because I didnt feel anything!
Scientists and oncologists say this new nanoparticle treatment could be a big step in the fight against cancer and have high hopes for the future of this kind of targeted therapy.
Cancer cells are very good at erecting a defense against foreign harmful substances, said Dr. Ramesh Ramanthan, M.D., medical director of Virginia G. Piper Cancer Center Clinical Trials. We think that nanoparticles may be the solution to penetrating cancer cells and delivering cancer drugs more effectively.
As for Sorensen, the future is looking much brighter than it did for her six months ago. She is now strong enough to return to work and is back to swimming and enjoying her life.
Its so hard to explain because at one moment youre trying to get your affairs in order and you only have a year to live, and then all of the sudden you are offered hope, a chance to live, said Sorensen. And I intend to take advantage of every moment of it.
Provided by Translational Genomics Research Institute
- TGen, Virginia G. Piper Cancer Center studying new breast cancer drug Jul 20, 2011 | not rated yet | 0
- FDA approves new skin cancer drug Feb 01, 2012 | not rated yet | 0
- New investigational compound targets pancreatic cancer cells Sep 15, 2010 | not rated yet | 0
- Results of new drug for pancreatic cancer patients published Oct 04, 2011 | not rated yet | 0
- 'Seena' clinical trials named for pancreatic cancer advocate Dec 01, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer May 19, 2013 | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer May 19, 2013 | not rated yet | 1
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer May 18, 2013 | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
13 hours ago | 4.8 / 5 (5) | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
13 hours ago | 5 / 5 (3) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
12 hours ago | 5 / 5 (1) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
12 hours ago | 5 / 5 (2) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
17 hours ago | not rated yet | 0
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
12 hours ago | 5 / 5 (1) | 0